The Technical Field "ペプチド" had 24 patent application filings in the most recent period (2023-01-01 to 2023-02-28). This is a significantly decreased of -218 filings (-90.1%) over 242 they had in the same period of the previous year (2022-01-01 to 2022-02-28). This report also includes technical terms related to " ペプチド化合物 ", " ペプチド類 ", " ペプタイド " in the search set.
The highest number of filings in 2016 with 2,518 cases, and their lowest number in 2022 with 1,463 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 10,217 cases in total) is 1,703, and the median is 1,923. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 1,703 patents |
Std Dev | 792 |
COV | 0.5 |
The number of filings has been decreasing for the last 3 years (2020 to 2023).
Year | Cases | YOY |
---|---|---|
2022 year | 1,463 cases | -24.47 % |
2021 year | 1,937 cases | +1.47 % |
2020 year | 1,909 cases | -18.84 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for ペプチド for the period of the last 10 years (2014-01-01 to 2024-10-31). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of ペプチド, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of ペプチド over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
This patent analysis report was created for a patent search set of 19,796 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as ペプチド are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 13 cases, followed by エフホフマン-ラロシュアーゲー with 11 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 13 cases |
エフホフマン-ラロシュアーゲー | 11 cases |
ジェネンテックインコーポレイテッド | 11 cases |
中外製薬株式会社 | 9 cases |
イマティクスバイオテクノロジーズゲーエムベーハー | 7 cases |
国立研究開発法人産業技術総合研究所 | 5 cases |
ノバルティスアーゲー | 5 cases |
武田薬品工業株式会社 | 2 cases |
味の素株式会社 | 2 cases |
株式会社島津製作所 | 1 cases |
Comparing the number of applications of each company, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 180 cases, followed by イマティクスバイオテクノロジーズゲーエムベーハー with 178 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 180 cases |
イマティクスバイオテクノロジーズゲーエムベーハー | 178 cases |
エフホフマン-ラロシュアーゲー | 133 cases |
ジェネンテックインコーポレイテッド | 127 cases |
ノバルティスアーゲー | 113 cases |
株式会社島津製作所 | 90 cases |
中外製薬株式会社 | 66 cases |
国立研究開発法人産業技術総合研究所 | 59 cases |
武田薬品工業株式会社 | 55 cases |
味の素株式会社 | 52 cases |
国立研究開発法人科学技術振興機構 | 7 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as ペプチド are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Among the top coapplicants, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 13 cases, followed by エフホフマン-ラロシュアーゲー with 11 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 13 cases |
エフホフマン-ラロシュアーゲー | 11 cases |
ジェネンテックインコーポレイテッド | 11 cases |
国立研究開発法人産業技術総合研究所 | 5 cases |
武田薬品工業株式会社 | 2 cases |
味の素株式会社 | 2 cases |
Among the top coapplicants, ザリージェンツオブザユニバーシティオブカリフォルニア has the highest number of joint applications in the last for the target period (2014 to 2024) with 180 cases, followed by エフホフマン-ラロシュアーゲー with 133 cases.
Name | Cases |
---|---|
ザリージェンツオブザユニバーシティオブカリフォルニア | 180 cases |
エフホフマン-ラロシュアーゲー | 133 cases |
ジェネンテックインコーポレイテッド | 127 cases |
国立研究開発法人産業技術総合研究所 | 59 cases |
武田薬品工業株式会社 | 55 cases |
味の素株式会社 | 52 cases |
国立研究開発法人科学技術振興機構 | 7 cases |
Below is a ranking of the number of JP patent applications by ペプチド’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by ペプチド’s top 7 coapplicants over the last 20 years.
ペプチド filed 55 joint applications with 武田薬品工業株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 29 cases in total) is 4.8, and the median is 5.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2016 with 12 cases, and their lowest number in 2015 with 0 cases.
Index | Value |
---|---|
Average | 4.8 patents |
Std Dev | 3.3 |
COV | 0.7 |
Year | Cases | YOY |
---|---|---|
2022 year | 2 cases | -75.0 % |
2021 year | 8 cases | +167 % |
2020 year | 3 cases | -62.5 % |
ペプチド filed 180 joint applications with ザリージェンツオブザユニバーシティオブカリフォルニア for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 93 cases in total) is 15.5, and the median is 14.5. The coefficient of variation (standard deviation/mean) is 0.7, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2018 with 35 cases, and their lowest number in 2022 with 13 cases.
Index | Value |
---|---|
Average | 15.5 patents |
Std Dev | 10.2 |
COV | 0.7 |
Year | Cases | YOY |
---|---|---|
2022 year | 13 cases | -13.33 % |
2021 year | 15 cases | -6.25 % |
2020 year | 16 cases | +14.29 % |
ペプチド filed 133 joint applications with エフホフマン-ラロシュアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 61 cases in total) is 10.2, and the median is 10.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been increasing for the last 3 years (2020 to 2023). The highest number of filings in 2017 with 23 cases, and their lowest number in 2020 with 6 cases.
Index | Value |
---|---|
Average | 10.2 patents |
Std Dev | 6.2 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 11 cases | +10.00 % |
2021 year | 10 cases | +66.7 % |
2020 year | 6 cases | -70.0 % |
ペプチド filed 52 joint applications with 味の素株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 21 cases in total) is 3.5, and the median is 1.5. The coefficient of variation (standard deviation/mean) is 1.3, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2019 with 13 cases, and their lowest number in 2022 with 0 cases.
Index | Value |
---|---|
Average | 3.5 patents |
Std Dev | 4.6 |
COV | 1.3 |
Year | Cases | YOY |
---|---|---|
2022 year | 0 cases | - |
2021 year | 0 cases | -100 % |
2020 year | 1 cases | -92.3 % |
ペプチド filed 59 joint applications with 国立研究開発法人産業技術総合研究所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 27 cases in total) is 4.5, and the median is 4.0. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 9 cases, and their lowest number in 2021 with 2 cases.
Index | Value |
---|---|
Average | 4.5 patents |
Std Dev | 2.8 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 4 cases | +100 % |
2021 year | 2 cases | -50.0 % |
2020 year | 4 cases | -42.9 % |
The following shows JP patents held by ペプチド that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and ペプチド’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which ペプチド is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 7 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.0 times. The most recently Invalidation Trial patent is 特許5419866 "新たな医薬組成物" (Invalidation Trial day 2024-05-30) , next is 特許6144713 "新たな医薬組成物" (Invalidation Trial day 2024-05-30) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許5419866 | 新たな医薬組成物 | 2024-05-30 |
2 | 特許6144713 | 新たな医薬組成物 | 2024-05-30 |
3 | 特許5735078 | 新たな医薬組成物 | 2024-05-30 |
4 | 特許6560289 | 新たな医薬組成物 | 2024-05-30 |
5 | 特許6814997 | 5’キャップ付RNAを合成するための組成物および方法 | 2024-05-15 |
6 | 特許5813293 | DPP IVインヒビターの使用 | 2023-03-07 |
7 | 特許6692856 | RNA依存性標的DNA修飾およびRNA依存性転写調節のための方法および組成物 | 2022-02-25 |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 6 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.0. The most invalidation trial patent is 特許6814997 "5’キャップ付RNAを合成するための組成物および方法" (1 times) , and the next most invalidation trial patent is 特許6144713 "新たな医薬組成物" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6814997 | 5’キャップ付RNAを合成するための組成物および方法 | 1 times |
2 | 特許6144713 | 新たな医薬組成物 | 1 times |
3 | 特許6035372 | 肺癌治療剤 | 1 times |
4 | 特許6258428 | 肺癌治療剤 | 1 times |
5 | 特許6293103 | 自己緩衝タンパク質製剤 | 1 times |
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 30 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7432791 "有機フッ素化合物非含有の耐アルコール型たん白泡消火薬剤" (Opposition day 2024-06-28) , next is 特許7364841 "酸ハロゲン化物による化合物の製造方法" (Opposition day 2024-04-18) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7432791 | 有機フッ素化合物非含有の耐アルコール型たん白泡消火薬剤 | 2024-06-28 |
2 | 特許7364841 | 酸ハロゲン化物による化合物の製造方法 | 2024-04-18 |
3 | 特許7341279 | ビールテイスト飲料 | 2024-03-08 |
4 | 特許7339261 | 低アレルゲン性の乳児用調製乳及びそれを調製する方法 | 2024-03-05 |
5 | 特許7289655 | PAMPS及びDAMPSの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2023-12-12 |
6 | 特許7270912 | アドレノメデュリン濃度変動による予後予測の情報提供方法及びその試薬 | 2023-11-13 |
7 | 特許7265834 | 植物エキス末の製造方法 | 2023-10-26 |
8 | 特許7237544 | 小児の胆汁うっ滞性肝疾患の処置のための胆汁酸再循環阻害剤 | 2023-09-11 |
9 | 特許7232758 | 膜透過性の高い環状ペプチド化合物、及びこれを含むライブラリ | 2023-09-05 |
10 | 特許7222347 | 可溶性タンパク質に対する親和性物質、切断性部分および反応性基を有する化合物またはその塩 | 2023-08-11 |
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 41 patents Protest from third parties. The average number of Protest is 1.8 times. The most recently Protest patent is 特開2022-183114 "ゼラチンカプセル崩壊遅延低減剤、ゼラチンカプセル、及びゼラチンカプセル用皮膜" (Protest day 2024-09-02) , next is 再公表2019/240288 "抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩" (Protest day 2024-08-08) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特開2022-183114 | ゼラチンカプセル崩壊遅延低減剤、ゼラチンカプセル、及びゼラチンカプセル用皮膜 | 2024-09-02 |
2 | 再公表2019/240288 | 抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩 | 2024-08-08 |
3 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-06-15 |
4 | 特開2021-116244 | 高純度プロタミン硫酸塩 | 2024-05-29 |
5 | 特開2022-164766 | 糖質ゼロのビールテイスト発酵アルコール飲料 | 2024-05-01 |
6 | 再公表2019/050017 | バイオチップ用基体、バイオチップ、バイオチップの製造方法およびその保存方法 | 2024-04-22 |
7 | 特表2023-525856 | ATI消化のための方法及び組成物 | 2024-02-28 |
8 | 特開2023-055917 | PAMPS及びDAMPSの除去への血液適合性多孔性ポリマービーズ吸着剤の使用 | 2024-01-17 |
9 | 特表2023-531816 | 新規なアテロコラーゲンおよびその用途 | 2023-12-13 |
10 | 特許7438604 | SARS-COV-2 mRNAドメインワクチン | 2023-10-27 |
11 | 特許7392011 | 糖質ゼロのビールテイスト発酵アルコール飲料 | 2023-09-22 |
12 | 特許7362715 | 低糖質ビールテイスト発酵アルコール飲料およびその製造方法 | 2023-08-04 |
13 | 再公表2019/189882 | NCC−ST−439抗原と特異的に反応するモノクローナル抗体およびその製造方法。 | 2023-07-20 |
14 | 特表2021-503278 | CasZ組成物及び使用方法 | 2023-07-06 |
15 | 特開2021-191309 | 雑味が低減されたビールテイスト飲料 | 2023-03-31 |
16 | 特許7524214 | 抗体コード配列をセーフハーバー遺伝子座に挿入するための方法および組成物 | 2023-03-24 |
17 | 特許7335078 | ペプチド含有物を含む組成物の変色抑制方法、並びに粉末組成物、顆粒、及び錠剤 | 2023-03-14 |
18 | 特開2021-120383 | 免疫機能を調節するため及び腸の炎症を治療するためのベータ−1,3−グルカンの使用 | 2023-03-13 |
19 | 特開2020-065547 | ゼリー食品及びその製造方法 | 2023-03-01 |
20 | 特許7486956 | シュー皮用油脂組成物 | 2023-01-16 |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 98 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.4. The most protest patent is 特許7136852 "糖質ゼロのビールテイスト発酵アルコール飲料" (4 times) , and the next most protest patent is 特許7103980 "糖質ゼロのビールテイスト発酵アルコール飲料" (4 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許7136852 | 糖質ゼロのビールテイスト発酵アルコール飲料 | 4 times |
2 | 特許7103980 | 糖質ゼロのビールテイスト発酵アルコール飲料 | 4 times |
3 | 特許7154994 | 飲み応えが付与されたビールテイスト発酵アルコール飲料およびその製造方法 | 4 times |
4 | 再公表2019/240288 | 抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩 | 4 times |
5 | 特許6975516 | 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物 | 3 times |
In the last 3 years (2021-11-01 ~ 2024-10-31), there were 310 patents Inspection from third parties. The average number of Inspection is 1.6 times. The most recently Inspection patent is 特許7560815 "多血症治療薬" (Inspection day 2024-09-20) , next is 特表2021-517895 "HPV関連疾患を処置するための方法" (Inspection day 2024-09-19) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特許7560815 | 多血症治療薬 | 2024-09-20 |
2 | 特表2021-517895 | HPV関連疾患を処置するための方法 | 2024-09-19 |
3 | 特表2022-514618 | PD-L1に特異的な二環式ペプチドリガンド | 2024-09-18 |
4 | 再公表2019/240288 | 抗体に対する親和性物質、および生体直交性官能基を有する化合物またはその塩 | 2024-09-17 |
5 | 特表2023-517644 | コロナウイルスワクチン組成物及び方法 | 2024-09-13 |
6 | 特表2021-519069 | 遺伝子改変リンパ球の製造方法 | 2024-09-06 |
7 | 特表2022-514255 | PSMAに特異的な二環式ペプチドリガンド | 2024-09-05 |
8 | 特開2023-071635 | 分子標的薬nCoVshRNA・2ACE2の合成方法 | 2024-09-05 |
9 | 特表2022-537670 | CA2の組成物および調整可能な制御方法 | 2024-09-05 |
10 | 特開2023-089182 | 腫瘍状微小環境を変調する方法 | 2024-09-03 |
11 | 特表2022-527763 | 修飾環状ポリリボヌクレオチドを含む組成物及びその使用 | 2024-08-30 |
12 | 特開2023-002670 | 認知障害を治療または予防するためのヒト化抗体、その製造プロセス、及びそれを用いた認知障害を治療または予防するための薬剤 | 2024-08-23 |
13 | 特表2024-520444 | 1型糖尿病を治療するための方法 | 2024-08-14 |
14 | 特表2024-521164 | 感染後自己免疫性糖尿病を治療するための方法 | 2024-08-14 |
15 | 特表2023-530109 | 1型糖尿病を予防するための方法および組成物 | 2024-08-14 |
16 | 特表2023-503046 | ポンペ病およびリソソーム障害を処置するための肝臓特異的プロモーターを含む治療用アデノ随伴ウイルス | 2024-08-02 |
17 | 特表2021-528959 | 細胞内で存続する遺伝子送達のためのベクター | 2024-07-30 |
18 | 特表2021-514661 | サイトカインに連結させたECM親和性ペプチドを用いてがんを処置するための方法および組成物 | 2024-07-30 |
19 | 特表2021-518345 | 喘息またはアレルギー性疾患を処置するための方法 | 2024-07-23 |
20 | 特開2020-078293 | 高純度酸化鉄ナノ粒子の細胞での生産 | 2024-07-17 |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 569 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.3. The most inspection patent is 特許7265834 "植物エキス末の製造方法" (15 times) , and the next most inspection patent is 特許6025881 "高純度PTH含有凍結乾燥製剤およびその製造方法" (13 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許7265834 | 植物エキス末の製造方法 | 15 times |
2 | 特許6025881 | 高純度PTH含有凍結乾燥製剤およびその製造方法 | 13 times |
3 | 特許7136852 | 糖質ゼロのビールテイスト発酵アルコール飲料 | 9 times |
4 | 特許7154994 | 飲み応えが付与されたビールテイスト発酵アルコール飲料およびその製造方法 | 9 times |
5 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから,細胞を保護する組成物 | 8 times |
Of the patent applications filed in the last 10 years (2014-11-01 to 2024-10-31), 2,456 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.1. The most cited patent is 特開2016-106631 "非ヒト哺乳動物" (27 times) , and the next most cited patent is 特許6746275 "低糖質ビールテイストアルコール飲料およびその製造方法" (24 times) .
- | No. | Title | |
---|---|---|---|
1 | 特開2016-106631 | 非ヒト哺乳動物 | 27 times |
2 | 特許6746275 | 低糖質ビールテイストアルコール飲料およびその製造方法 | 24 times |
3 | 特表2018-527052 | 育毛を促進するための装置、システムおよび方法 | 23 times |
4 | 特許6625690 | PSMA結合性リガンド−リンカー結合体及び使用方法 | 23 times |
5 | 特許6345800 | 抗体−フィノマー複合体 | 22 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International